Literature DB >> 24788502

Post-operative outcomes of atypical femoral subtrochanteric fracture in patients on bisphosphonate therapy.

B J X Teo1, J S B Koh, S K Goh, M A Png, D T C Chua, T S Howe.   

Abstract

Management of bisphosphonate-associated subtrochanteric fractures remains opinion- or consensus-based. There are limited data regarding the outcomes of this fracture. We retrospectively reviewed 33 consecutive female patients with a mean age of 67.5 years (47 to 91) who were treated surgically between May 2004 and October 2009. The mean follow-up was 21.7 months (0 to 53). Medical records and radiographs were reviewed to determine the post-operative ambulatory status, time to clinical and radiological union and post-fixation complications such as implant failure and need for second surgery. The predominant fixation method was with an extramedullary device in 23 patients. 25 (75%) patients were placed on wheelchair mobilisation or no weight-bearing initially. The mean time to full weight-bearing was 7.1 months (2.2 to 29.7). The mean time for fracture site pain to cease was 6.2 months (1.2 to 17.1). The mean time to radiological union was 10.0 months (2.2 to 27.5). Implant failure was seen in seven patients (23%, 95 confidence interval (CI) 11.8 to 40.9). Revision surgery was required in ten patients (33%, 95 CI 19.2 to 51.2). A large proportion of the patients required revision surgery and suffered implant failure. This fracture is associated with slow healing and prolonged post-operative immobility.

Entities:  

Keywords:  atypical subtrochanter fracture bisphosphonate union outcome

Mesh:

Substances:

Year:  2014        PMID: 24788502     DOI: 10.1302/0301-620X.96B5.32887

Source DB:  PubMed          Journal:  Bone Joint J        ISSN: 2049-4394            Impact factor:   5.082


  29 in total

1.  Atypical femur fracture during bisphosphonate drug holiday: a case series.

Authors:  A J Lovy; S M Koehler; A Keswani; D Joseph; R Hasija; R Ghillani
Journal:  Osteoporos Int       Date:  2015-04-02       Impact factor: 4.507

Review 2.  Surgical Treatment of the Atypical Femoral Fracture: Overcoming Femoral Bowing.

Authors:  Kyung-Jae Lee; Byung-Woo Min
Journal:  Hip Pelvis       Date:  2018-12-06

3.  A review of atypical subtrochanteric femoral fractures in Northern Ireland between 2010 and 2014.

Authors:  K J Donnelly; A Tucker; B Kerr; S McDonald; D S O'Longain; J D Acton
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-12-22

4.  Atraumatic segmental atypical femur fracture secondary to bisphosphonate use: A case report.

Authors:  Andrew J Lovy; Diana Patterson; Laura Skeeles; Richard Ghillani; David Joseph; Yangguan Wu; Rohit Hasija
Journal:  J Clin Orthop Trauma       Date:  2017-03-19

5.  Undisturbed local bone formation capacity in patients with atypical femoral fractures: a case series.

Authors:  H P Bögl; P Aspenberg; J Schilcher
Journal:  Osteoporos Int       Date:  2017-05-04       Impact factor: 4.507

Review 6.  Epidemiology and Postoperative Outcomes of Atypical Femoral Fractures in Older Adults: A Systematic Review.

Authors:  K S F Khow; P Shibu; S C Y Yu; M J Chehade; R Visvanathan
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

7.  Atypical femur fractures in patients receiving bisphosphonate therapy: etiology and management.

Authors:  Laura Blum; Karen Cummings; James A Goulet; Aaron M Perdue; Cyril Mauffrey; Mark E Hake
Journal:  Eur J Orthop Surg Traumatol       Date:  2016-03-04

Review 8.  Delayed healing of lower limb fractures with bisphosphonate therapy.

Authors:  B Yue; A Ng; H Tang; S Joseph; M Richardson
Journal:  Ann R Coll Surg Engl       Date:  2015-07       Impact factor: 1.891

Review 9.  Simultaneous bilateral atypical femoral fracture in a patient receiving denosumab: case report and literature review.

Authors:  J Selga; J H Nuñez; J Minguell; M Lalanza; M Garrido
Journal:  Osteoporos Int       Date:  2016-02       Impact factor: 4.507

10.  Histological study of atraumatic periprosthetic fractures: does atypical periprosthetic fracture exist?

Authors:  Vanna Bottai; Gaia De Paola; Fabio Celli; Ilaria Lazzerini; Valerio Ortenzi; Antonio Giuseppe Naccarato; Giulio Guido; Rodolfo Capanna; Stefano Giannotti
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.